FDA Inspection 1201064 — Octapharma Plasma Inc
The FDA completed an inspection of Octapharma Plasma Inc on March 9, 2023 in Memphis, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 9, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Memphis, TN (United States)